Anthem Biosciences Q4 FY26 Results: Revenue, Profit and Share Price Reaction
Anthem Biosciences' quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.
Every quarter
| Quarter | Announced | Revenue | YoY | Net profit | YoY | Margin | EPS | Price reaction |
|---|---|---|---|---|---|---|---|---|
| Q4 FY26 | — | 611 | — | 190 | — | 31.1% | 3.38 | — |
₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.
Questions
What were Anthem Biosciences' Q4 FY26 results?
For the quarter to 31 Mar 2026, Anthem Biosciences reported revenue of ₹611 crore and net profit of ₹190 crore, with basic EPS of ₹3.38.
When is Anthem Biosciences' next results date?
No results date has been announced to NSE yet. Companies give advance notice of the board meeting; the results calendar lists every announced date.
About this data
From Anthem Biosciences' Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See ANTHEM stock page for price, open interest and deals, all results declared this week and the results calendar, and ANTHEM dividend history.